M.D., Ph.D., Director of Laboratory Science, Palmetto GBA (MolDX)
Girish Putcha is currently Director of Laboratory Science for Palmetto GBA’s MolDX program, and the founding Medical Director for Orion Genomics, a personalized medicine company focused in oncology. Previously, Girish was the founding Laboratory Director and/or Chief Medical Officer at Ariosa Diagnostics, Crescendo Bioscience, Life Technologies, and VitaPath Genetics. Prior to this, he focused on investments across healthcare, from biopharmaceuticals and medical devices to diagnostics and services, at Panorama Capital and RiverVest Venture Partners. He also held various positions at Veracyte, CardioDx, and Aviir, all venture-funded personalized medicine companies.
MolDX 2016: Updates and Lessons Learned
Palmetto’s MolDX is a pilot program launched in 2011 that attempts to make more transparent, consistent and robust the mechanisms by which molecular tests are coded, covered and reimbursed. During this presentation, we will briefly review the technical assessment process at MolDX, and how it continues to evolve.